Veri MedTech Holdings, Inc. (VRHI) RSU sell-vs-hold
Calculator · free · no signup · VRHISell at vest or hold? Compare after-tax payout from selling Veri MedTech Holdings, Inc. RSUs at vest vs. holding through the LTCG cliff at 12 months.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Your vest
Tax inputs
Hold strategy
@ 20.0% / yr
Best after-tax payout — at year 1 yr
$47,823
Sell + invest wins by $4,992 over Hold 1 yr.
Estimates only. Not financial advice.
Heads-up: under-withholding. Your employer withholds federal tax at the IRS supplemental rate (22.0% on this vest, ≈ $17,600). Your marginal federal rate on this vest is 32.6%, owing $26,065. Expect to settle the $8,465 gap at tax time.
The hidden purchase
Tax was paid at vest either way. Holding is mathematically equivalent to taking $44,615 in after-tax cash and buying $44,615 of VRHI today.
Most diversification frameworks would suggest no, but the right answer depends on your conviction in VRHI. Holding past one year converts the gain to LTCG.
Sell + invest
Best payout| Vest value (shares × price) | $80,000 |
| Federal | |
| State | |
| Medicare | −$1,160 |
| Additional Medicare | −$720 |
| Market gain over 1 yr at 10.0% | $4,462 |
| Cap-gain tax on diversified gain — LTCG (federal + state + NIIT) | −$1,254 |
| Net at year 1 yr | $47,823 |
Sell every share at vest; invest the after-tax cash at the market return for 1 yr, then liquidate. Diversified — no single-stock concentration risk.
Hold 1 yr
| Vest value (shares × price) | $80,000 |
| Vest tax (federal + state + FICA) | |
| Net at year 1 yr | $42,830 |
Sold 442 shares to cover vest tax (net-settled); kept 558 shares 1 yr to qualify for long-term capital gains.
Social Security + Medicare are payroll taxes (collectively called FICA) — they apply because you're still employed at vest.
Both columns are stated in year-1 yr dollars. The sell side compounds at the market return; the hold side compounds at your single-stock expected return after a 20% volatility drag.
Estimates only. Assumes net-settled (sell-to-cover) vesting; double-trigger and pre-IPO RSUs are out of scope. Excludes multi-state moves, AMT interactions on other equity, and 83(b) elections. Not financial advice.
About Veri MedTech Holdings, Inc.
Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company.
OTC; cannabis telehealth.
Equity grants at Veri MedTech Holdings, Inc. typically include incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs).
Joshua Green and Samuel Adetunji founded Veriheal in McLean, Virginia in 2017 to connect patients with state-licensed physicians for medical marijuana card services. The parent holding company, Veri MedTech Holdings, Inc., reported roughly $22 million in revenue in 2023 and $17 million in 2024. The company trades on the OTC market under ticker VRHI and is pursuing a $15 million Nasdaq uplisting at $4 per share, though auditors have flagged going-concern uncertainty pending the additional capital.
Sources: stocktitan.net · businessofcannabis.com
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Veri MedTech Holdings, Inc..
Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company. OTC; cannabis telehealth. RSUs vest as ordinary income at the price on vest day. The decision is whether to sell at vest and reinvest, or hold the shares through the 12-month LTCG cliff. This calculator runs both paths through the same after-tax math so you can compare like-for-like.
All Veri MedTech Holdings, Inc. tools → · Use the generic RSU Sell-vs-Hold Calculator for any company.
One piece of the puzzle.
OptionsAhoy plans your Veri MedTech Holdings, Inc. equity alongside hedging, vesting, and de-concentration — across bullish, neutral, and bearish market scenarios. Free during beta.